Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Christel Iffland, Ph.D.

Vice President, Antibody Technologies at Ligand Pharmaceuticals


Dr. Iffland received her Ph.D. in Molecular and Cell Biology from the Université de Nice Sophia-Antipolis (France) and completed her post-doctoral research training at the Albert Einstein College of Medicine and the Dana-Farber Cancer Institute. In 2000, she joined EMD Serono where she worked on antibody characterization, phage display and single B cell cloning. Dr. Iffland joined Ligand in 2017 to support current and new partnerships and collaborations for the OmniAb franchise, providing scientific guidance and input.